These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy. Fitton A, Goa KL. Drugs; 1995 Oct; 50(4):691-713. PubMed ID: 8536554 [Abstract] [Full Text] [Related]
3. Review of lamotrigine and its clinical applications in epilepsy. Choi H, Morrell MJ. Expert Opin Pharmacother; 2003 Feb; 4(2):243-51. PubMed ID: 12562315 [Abstract] [Full Text] [Related]
8. Adjunctive therapy for the treatment of primary generalized tonic-clonic seizures: focus on once-daily lamotrigine. Steinbaugh L, Szaflarski JP. Drug Des Devel Ther; 2010 Nov 18; 4():337-42. PubMed ID: 21151621 [Abstract] [Full Text] [Related]
9. A randomised double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy. Sander JW, Patsalos PN, Oxley JR, Hamilton MJ, Yuen WC. Epilepsy Res; 1990 Aug 18; 6(3):221-6. PubMed ID: 2272345 [Abstract] [Full Text] [Related]
10. Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy. Goa KL, Ross SR, Chrisp P. Drugs; 1993 Jul 18; 46(1):152-76. PubMed ID: 7691504 [Abstract] [Full Text] [Related]
11. Assessment of tolerability in elderly patients: changing to lamotrigine therapy. Evans BK, Kustra RP, Hammer AE. Am J Geriatr Pharmacother; 2007 Jun 18; 5(2):112-9. PubMed ID: 17719513 [Abstract] [Full Text] [Related]
12. Lamotrigine in absence and primary generalized epilepsies. Mikati MA, Holmes GL. J Child Neurol; 1997 Nov 18; 12 Suppl 1():S29-37. PubMed ID: 9429128 [Abstract] [Full Text] [Related]
13. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Smith D, Baker G, Davies G, Dewey M, Chadwick DW. Epilepsia; 1993 Nov 18; 34(2):312-22. PubMed ID: 8453943 [Abstract] [Full Text] [Related]
14. A survey comparing lamotrigine and vigabatrin in everyday clinical practice. Schapel G, Chadwick D. Seizure; 1996 Dec 18; 5(4):267-70. PubMed ID: 8952011 [Abstract] [Full Text] [Related]
16. [Vigabatrin and lamotrigin: experiences with 2 new anticonvulsants in the Swiss epilepsy clinic]. Vogt H, Krämer G. Schweiz Med Wochenschr; 1995 Jan 28; 125(4):125-32. PubMed ID: 7878401 [Abstract] [Full Text] [Related]
17. Role of vigabatrin and lamotrigine in treatment of childhood epileptic syndromes. Bélanger S, Coulombe G, Carmant L. Epilepsia; 1998 Aug 28; 39(8):878-83. PubMed ID: 9701380 [Abstract] [Full Text] [Related]
18. A pharmacological overview of lamotrigine for the treatment of epilepsy. Yasam VR, Jakki SL, Senthil V, Eswaramoorthy M, Shanmuganathan S, Arjunan K, Nanjan MJ. Expert Rev Clin Pharmacol; 2016 Dec 28; 9(12):1533-1546. PubMed ID: 27825017 [Abstract] [Full Text] [Related]
19. [Effectiveness and role of lamotrigine in the paradigm shift towards new antiepileptic drugs: a therapeutic strategy proposed after an investigation of a large number of cases at a single hospital]. Yamamoto T, Yamazoe T, Fujimoto A, Kobayashi R, Yokota T, Okanishi T, Uchiyama G, Ohashi T, Tanaka T, Enoki H. Brain Nerve; 2014 Jan 28; 66(1):59-69. PubMed ID: 24371132 [Abstract] [Full Text] [Related]
20. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients. Zeng K, Wang X, Xi Z, Yan Y. Clin Neurol Neurosurg; 2010 May 28; 112(4):291-5. PubMed ID: 20071075 [Abstract] [Full Text] [Related] Page: [Next] [New Search]